Abstract
The ideal drug for the treatment of hypercholesterolemia should be effective, free of subjective side-effects and of objective toxicity. The cholesterol analog, beta-sitosterol (Fig. 1), comes close to that ideal. The experience with three different sitosterol preparations over the last several years will be reported touching upon both their efficacy and their side-effects.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
FREDRICKSON, D.S., LEES, R.S.: Circulation 31, 321–327 (1965).
LEES, R.S., WILSON, D.E., SCHONFELD, G., FLEET, S Prog. med. Genetics 9, 237–290 (1973).
LEES, R.S., WILSON, D.E.: New Engl. J. Med. 284, 186–195 (1971).
HATCH, F.T., LEES, R.S.: Advanc. Lipid Res. 6., 1–68 (1968).
SALEN, G., AHRENS, E.H., Jr., GRUNDY, S.M.: J. clin. Invest. 49, 952–967 (1970).
STAMLER, J. et al. (The Coronary Drug Project Research Group): J. Amer. med. Ass. 231, 360–381 (1975).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Lees, R.S., Lees, A.M. (1976). Effects of Sitosterol Therapy on Plasma Lipid and Lipoprotein Concentrations. In: Greten, H. (eds) Lipoprotein Metabolism. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66323-9_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-66323-9_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-07635-3
Online ISBN: 978-3-642-66323-9
eBook Packages: Springer Book Archive